Institute for International Research

Scientific Advisory Committee:

• Reed Harris, Director, Analytical Development, Genentech, Inc.
• John P. Hennessey, Jr., Ph.D., Independent Consultant (formerly Senior Director, Bioprocess Research and Development, Merck & Co., Inc.)
• Alan V. Klotz, Ph.D., Research Advisor, Process R&D Six Sigma, Eli Lilly and Company
• Joseph Kutza, Ph.D., Associate Director, CMC Regulatory Affairs, MedImmune
• Ned Mozier, Ph.D., Director, Analytical Sciences, Global Biologics, Research and Development, Pfizer, Inc.
• Michael G. Mulkerrin, Ph.D., Vice President, Process Development, OncoMed Pharmaceuticals
• Donald S. Neblock, Ph.D., Senior Director, BioProcess Technology Department, Worldwide Technical Operations, Global Biologics Supply Chain, L.L.C.
• Nadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group, Inc.
• Richard Strong, Ph.D., Scientist II, Analytical Development, Biogen Idec
• Steve Swanson, Ph.D., Executive Director, Medical Sciences, Clinical Immunology, Amgen Inc.
• Bruce Tangarone, Senior Research Scientist II, Wyeth Biopharma

Distinguished Faculty:

• Darrell R. Abernethy, M.D., Ph.D., U.S. Pharmacopeia
• Ali Al-Hakim, Ph.D., CDER, US FDA
• Svetlana Bergelson, Ph.D., Biogen Idec
• Andrew C. Chang, Ph.D., PharmaNet Development Group, Inc.
• Edward K. Chess, Ph.D., Baxter Healthcare Corporation
• Mary Cromwell, Genentech, Inc.
• Aparna Deora, Ph.D., Pfizer Inc.
• Thomas M. Dillon, Amgen Inc.
• Roman T. Drews, Ph.D., CBER, US FDA
• Patrick Dunlap, Eli Lilly and Company
• Laurent J. Fanget, M.Sc., PDL BioPharma, Inc.
• Michelle Frazier-Jessen. Ph.D., MedImmune
• Robert L. Garnick, Ph.D., Genentech, Inc.
• John P. Hennessey, Jr., Ph.D., (formerly Merck & Co., Inc.)
• Steven Kozlowski, Ph.D., CDER, US FDA
• Joseph Kutza, Ph.D., MedImmune
• Carla S. Lankford, M.D., Ph.D., CDER, US FDA
• Alex Lazar, Ph.D., ImmunoGen, Inc.
• Dingjiang Liu, Amgen Inc.
• Amir Malek, Ph.D., Genentech, Inc.
• Adriana E. Manzi, Ph.D., Atheln
• Allen Minton, Ph.D., National Institutes of Health
• Wenjun (David) Mo, Ph.D., MedImmune, Inc.
• Jamie M. Moore, Ph.D., Genentech, Inc.
• Paul Motchnik, Ph.D., Genentech, Inc.
• Ned Mozier, Ph.D., Pfizer, Inc.
• Michael G. Mulkerrin, Ph.D., OncoMed Pharmaceuticals
• Donald S. Neblock, Ph.D., Global Biologics Supply Chain, L.L.C.
• Pankaj Oberoi, Ph.D., Meso Scale Discovery
• SungAe Suhr Park, Ph.D., Amgen Inc.
• Stephen Raso, Ph.D., Wyeth BioPharma
• Barbara Rellahan, Ph.D., CDER, US FDA
• Nadine M. Ritter, Ph.D., Biologics Consulting Group, Inc.
• Kevin R. Rupprecht, Ph.D., Abbott Laboratories
• Peter Schuck, Ph.D., National Institutes of Health
• Emily Shacter, Ph.D., CDER, US FDA
• Eric G. Stefanich, Genentech, Inc.
• Richard Strong, Ph.D., Biogen Idec
• Bruce Tangarone, Wyeth Biopharma
• Martin Vanderlaan, Ph.D., MBA, Genentech, Inc.
• Hannelore Willkommen, Ph.D., Regulatory Affairs and Biological Safety Consulting, Germany
• Yongjian Wu, Ph.D., Genentech, Inc.